Top Key Companies for Digital Health and Digital Therapeutics Market: Canary Health, Livongo, My mHealth, Omada, Proteus, Virgin Pulse, DarioHealth Corp, 2Morrow, Click Therapeutics, CureApp, AppliedVR, Virta Health, Biofourmis, Akili Interactive, Pear Therapeutics, One Drop, Lark Health, Propeller Health, Cognoa, Kaia Health, Happify Health.
Global Digital Health and Digital Therapeutics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Digital Health and Digital Therapeutics Market Overview And Scope:
The Global Digital Health and Digital Therapeutics Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Digital Health and Digital Therapeutics utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Digital Health and Digital Therapeutics Market Segmentation
By Type, Digital Health and Digital Therapeutics market has been segmented into:
Software
Hardware
By Application, Digital Health and Digital Therapeutics market has been segmented into:
Mental Illness
Respiratory Diseases
Nervous System Diseases
Other
Regional Analysis of Digital Health and Digital Therapeutics Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Digital Health and Digital Therapeutics Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Digital Health and Digital Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Digital Health and Digital Therapeutics market.
Top Key Companies Covered in Digital Health and Digital Therapeutics market are:
Canary Health
Livongo
My mHealth
Omada
Proteus
Virgin Pulse
DarioHealth Corp
2Morrow
Click Therapeutics
CureApp
AppliedVR
Virta Health
Biofourmis
Akili Interactive
Pear Therapeutics
One Drop
Lark Health
Propeller Health
Cognoa
Kaia Health
Happify Health
Key Questions answered in the Digital Health and Digital Therapeutics Market Report:
1. What is the expected Digital Health and Digital Therapeutics Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Digital Health and Digital Therapeutics Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Digital Health and Digital Therapeutics Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Digital Health and Digital Therapeutics Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Digital Health and Digital Therapeutics companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Digital Health and Digital Therapeutics Markets?
7. How is the funding and investment landscape in the Digital Health and Digital Therapeutics Market?
8. Which are the leading consortiums and associations in the Digital Health and Digital Therapeutics Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Digital Health and Digital Therapeutics Market by Type
5.1 Digital Health and Digital Therapeutics Market Overview Snapshot and Growth Engine
5.2 Digital Health and Digital Therapeutics Market Overview
5.3 Software
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Software: Geographic Segmentation
5.4 Hardware
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hardware: Geographic Segmentation
Chapter 6: Digital Health and Digital Therapeutics Market by Application
6.1 Digital Health and Digital Therapeutics Market Overview Snapshot and Growth Engine
6.2 Digital Health and Digital Therapeutics Market Overview
6.3 Mental Illness
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Mental Illness: Geographic Segmentation
6.4 Respiratory Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Respiratory Diseases: Geographic Segmentation
6.5 Nervous System Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Nervous System Diseases: Geographic Segmentation
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Digital Health and Digital Therapeutics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Digital Health and Digital Therapeutics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Digital Health and Digital Therapeutics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CANARY HEALTH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 LIVONGO
7.4 MY MHEALTH
7.5 OMADA
7.6 PROTEUS
7.7 VIRGIN PULSE
7.8 DARIOHEALTH CORP
7.9 2MORROW
7.10 CLICK THERAPEUTICS
7.11 CUREAPP
7.12 APPLIEDVR
7.13 VIRTA HEALTH
7.14 BIOFOURMIS
7.15 AKILI INTERACTIVE
7.16 PEAR THERAPEUTICS
7.17 ONE DROP
7.18 LARK HEALTH
7.19 PROPELLER HEALTH
7.20 COGNOA
7.21 KAIA HEALTH
7.22 HAPPIFY HEALTH
Chapter 8: Global Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Software
8.2.2 Hardware
8.3 Historic and Forecasted Market Size By Application
8.3.1 Mental Illness
8.3.2 Respiratory Diseases
8.3.3 Nervous System Diseases
8.3.4 Other
Chapter 9: North America Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Software
9.4.2 Hardware
9.5 Historic and Forecasted Market Size By Application
9.5.1 Mental Illness
9.5.2 Respiratory Diseases
9.5.3 Nervous System Diseases
9.5.4 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Software
10.4.2 Hardware
10.5 Historic and Forecasted Market Size By Application
10.5.1 Mental Illness
10.5.2 Respiratory Diseases
10.5.3 Nervous System Diseases
10.5.4 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Software
11.4.2 Hardware
11.5 Historic and Forecasted Market Size By Application
11.5.1 Mental Illness
11.5.2 Respiratory Diseases
11.5.3 Nervous System Diseases
11.5.4 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Software
12.4.2 Hardware
12.5 Historic and Forecasted Market Size By Application
12.5.1 Mental Illness
12.5.2 Respiratory Diseases
12.5.3 Nervous System Diseases
12.5.4 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Software
13.4.2 Hardware
13.5 Historic and Forecasted Market Size By Application
13.5.1 Mental Illness
13.5.2 Respiratory Diseases
13.5.3 Nervous System Diseases
13.5.4 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Digital Health and Digital Therapeutics Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Software
14.4.2 Hardware
14.5 Historic and Forecasted Market Size By Application
14.5.1 Mental Illness
14.5.2 Respiratory Diseases
14.5.3 Nervous System Diseases
14.5.4 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Digital Health and Digital Therapeutics Scope:
|
Report Data
|
Digital Health and Digital Therapeutics Market
|
|
Digital Health and Digital Therapeutics Market Size in 2025
|
USD XX million
|
|
Digital Health and Digital Therapeutics CAGR 2025 - 2032
|
XX%
|
|
Digital Health and Digital Therapeutics Base Year
|
2024
|
|
Digital Health and Digital Therapeutics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Canary Health, Livongo, My mHealth, Omada, Proteus, Virgin Pulse, DarioHealth Corp, 2Morrow, Click Therapeutics, CureApp, AppliedVR, Virta Health, Biofourmis, Akili Interactive, Pear Therapeutics, One Drop, Lark Health, Propeller Health, Cognoa, Kaia Health, Happify Health.
|
|
Key Segments
|
By Type
Software Hardware
By Applications
Mental Illness Respiratory Diseases Nervous System Diseases Other
|